Analysis of proviral load levels in HTLV-1 carriers with different neurological impairment conditions
DOI:
https://doi.org/10.33448/rsd-v10i3.13264Keywords:
HTLV-1; Tropical Spastic Paraparesis; Neurological disorders; Proviral load.Abstract
Objectives: To analyze the levels of proviral load (CPV) in patients with HTLV-1 with different conditions of neurological impairment. Methodology: Cross-sectional study, conducted from March to October 2017, with 43 patients with HTLV-1, divided into three groups in decreasing order of neurological involvement, according to the updated proposal of the clinical diagnosis criteria for HAM / TSP: Defined for HAM / TSP (Group 1, n = 7); Probable / Possible for HAM / TSP (Group 2, n = 9); Without HAM / TSP (Group 3, n = 27). The ANOVA test (one criterion) was used to verify the difference between the groups' mean CPV (p-value≤0.05). Results: The groups presented the following average CPV values: G1 = 9.00 ± 11.18; G2 = 1.88 ± 3.92; G3 = 2.81 ± 4.03 copies / 106 PBMC. In the intergroup comparison, of the difference between the means of CPV, a significant difference was observed between groups 1 and 2 and between groups 1 and 3 (p <0.05); a significantly higher mean of CPV was not observed in the HTLV-1 infected groups with neurological impairment, compared to those infected without neurological impairment (p = 0.7063). Conclusion: CPV in patients with HTLV-1 seems to help the clinical evaluation of neurological impairment in the classification of classic cases of HAM/TSP, but it is not an important indicator of initial clinical conditions of HAM/TSP.
References
Araujo, A. Q. C., & Wedemann, D. (2019). HTLV-1 Associated Neurological Complex. What is Hidden below the Water? AIDS Reviews. 21,211-217.
Araujo, A. Q. C. (2019) Neurologic complications of HTLV-1: a review. Revista Brasileira de Neurologia. 55(2), 5-10.
Bangham, C. R., Araujo, A., Yamano, Y., & Taylor, G. P. (2015) HTLV-1-associated myelopathy/tropical spastic paraparesis. Nature Reviews Disease Primers. 1:15012.
Batista, E. S., Oliveira, P. D., Primo, J., Varandas, C. M. N., Nunes, A. P., Bittencourt, A.L, et al. (2019) HTLV-1 proviral load in infective dermatite associated with HTLV-1 does not increase after the development of HTLV-1-associated myelopathy/tropical spastic paraparesis and does not decrease after IDH remission. PLOS Neglected Tropical Diseases. 13(12):e0007705. https://doi.org/10.1371/journal.pntd.0007705.
Carneiro-Proietti, A. B. F., Proietti, F. A., & Catalan-Soares, B. C. (2002) Human T cell Lymphotropic viruses (HTLV/1-2) in South America: Should It Be a Public Health Concern? Journal Biomedic Sciece. 9, 587-95.
Carod-Artal, F. J. (2009) Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus. Reviews Neurology, 48,147-155.
Catalan-Soares, B. Carneiro-Proietti, A. B. F., & Proietti, F. A. (2005) Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil. Cadernos de Saúde Pública, 21 (3):926-993.
Cook, L. B., Cook, M., Elemans, A. G., & Rowan, B. (2013). Asquith HTLV-1: persistence and pathogenesis, Virology. 435, 131-140.
Da Costa, C. A., Furtado, K. C., Ferreira, L. S., Almeida, D. S., Linhares, A. C., Ishak, R., Vallinoto, A. C., Lemos, J. A., Martins, L. C., Ishikawa, E. A., Sousa, R. C., & Sousa, M. S. (2013). Familial transmission of human T-cell lymphotrophic virus: silent dissemination of an emerging but neglected infection. PLOS Neglected Tropical Diseases. 7(6), 1-7. https://doi.org/10.1371/journal.pntd.0002272.
De Castro-Costa, C. M. et al. (2006). Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS Research and Human Retroviruses. 22(10), 931-5.
De Thé, G., & Bomford, R. (1993). An HTLV-I vaccine: why, how, for whom?). AIDS Research and Human Retroviruses. 9(5):381-6.
Dehee, A., Cesaire, R., & Desire, N., et al. (2002). Quantificação da carga proviral de HTLV-I por um ensaio de PCR em tempo real TaqMan. Journal of Virological Methods, 102: 37-51.
Edlich, R. F., Hill, L. G., & Williams, F. M. (2003). Global epidemic of human T-cell lymphotrophic virus type-I (HTLV-I): an update. Journal of Long-Term Effects of Medical Implants. 13(2):127-40.
Ferreira, L. S. C., Costa, J. H. G., Costa, C. A., Melo, M. F. C, Andrade, M. L, Martins. L. C. Ishikawa, E. A. Y., & Sousa, M. S. (2010) Soroprevalência do vírus linfotrópico de células T humanas em comunidades ribeirinhas da região nordeste do Estado do Pará, Brasil. Revista Pan-Amazônica de Saúde, v.1, p.103-108.
Garcia, I. F. S., & Hennington, E. A. (2019). HTLV: uma infecção estigmatizante? Caderno de Saúde Pública. 35(11), e00005419. 10.1590/0102-311X00005419.
Gessain, A., & Mahieux, R. (2012). Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects. Revue Neurologique. Paris, 168, 3.
Grassi, M. F. R., Olavarria, V. N., Kruschewsky, R. A., Yamano, Y., Jacobson, S., Taylor, G. P., Martin, F., & Galvão-Castro, B. (2013). Utility of HTLV proviral load quantification in diagnosis of HTLV-1-associated myelopathy requires international standardization. Journal of Clinical Virology. 58(3): 584–586.
Grassi, M. R. F. G., Olavarria, V. N., Kruschewsky, R. A., Mascarenhas, R. E., Dourado, I., Correia, C. L. L., Castro-Costa, C. M., & Galvao-Castro, B. (2011) Human T Cell Lymphotropic Virus Type 1 (HTLV-1) Proviral Load of HTLV-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients According to New Diagnostic Criteria of HAM/TSP. Journal of Medical Virology. 83, 1269–1274.
Hashimoto, K. et al. (1998) Quantitative in situ PCR assay of HTLV-1 infected cells in peripheral blood lymphocytes of patients with ATL, HAM/TSP and asymptomatic carriers. Journal of the Neurological Science, Amsterdam, 159, (1)67-72.
Haziot, M. E., Gascon, M. R., Assone, T., Fonseca, L. A. M., Luiz, O. D. C., Smid, J., et al. (2019) Detection of clinical and neurological signs in apparently asymptomatic HTLV-1 infected carriers: Association with high proviral load. PLOS Neglected Tropical Diseases. 13(5): e0006967. https://doi.org/10.1371/journal.pntd.0006967.
Jeffery, K., et al. (1999) HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of associated myelopathy. Procedings of National Academy of Sciences United States of America, Washington, 96, 3848-3853.
Kaplan, J. E., Osame, M., Kubota, H., et al. (1990) The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. Journal of Acquired Immune Deficiency Syndromes. 3(11): 1096-101.
Koga, Y., Iwanaga, M., Soda, M., Inokuchi, N., Sasaki, D., Hasegawa, H., Yanagihara, K., et al. (2010). Trends in HTLV-1 prevalence and incidence of adult T-cell leukemia/lymphoma in Nagasaki, Japan. Journal of Medical Virology. 82(4):668-74.
Kondo, T., Kono, H., Miyamoto, N., Yoshida, R., Toki, H., Matsumoto, I., Hara, M., et al. (1989) Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. International Journal of Cancer.15, 43(6):1061-1064.
Kubota, R., et al. (1993) Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy. Journal of Neuroimmunology, Amsterdam, 42, 2,147-154.
Loureiro, P. (2008) Infecção pelo HTLV-1: diagnóstico e determinação da carga proviral em indivíduos assintomáticos e com enfermidades associadas em serviço de referência no Nordeste. Tese (Doutorado em Saúde Pública) - Centro de Pesquisas Aggeu Magalhães Fundação Oswaldo Cruz, Recife-PE.
Maloney, E. M., Cleghorn, F. R., Morgan, O. S., Rodgers-Johnson, P., Cranston, B., Jack, N., Blattner W. A., et al. (1998) Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad. Journal of Acquired Immune Deficiency Syndromes. 1; 17(2):167-70.
Manns, A., Hisada, M., & Grenade, L. L. (1999) Human T-lymphotropic virus type I infection. Lancet, London, 33 (9168): 1951-1958.
Martin, F., Fedina, A., Youshya, S., & Taylor, G. P. (2010). A 15-year prospective longi- tudinal study of disease progression in patients with HTLV-1 associated myelopathy in the UK. Journal of Neurology, Neurosurgery and Psychiatry. 81:1336-40.
Montanheiro, P. A., et al. Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. Brazilian Journal Medical Biological Research, Ribeirão Preto, 38(11), 2005. <http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100879X2005001100011&lng=en&nrm=iso>.
Nagai, M., et al. (1998) Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. Journal of Neurovirology, Houndmills, 4, (6):586-593.
Olavarria, V. N. G., et al. (2006) HTLV-1 proviral load in peripheral mononuclear cell quantified in TSP/HAM patients, asymptomatic and oligosymptomatic HTLV-1 carries. In: Simpósio Internacional Sobre Htlv No Brasil, 9, 2006, Belo Horizonte, Temas livres. Uberaba: Sociedade Brasileira de Medicina Tropical, 102.
Oliveira-Filho, A. B., Araújo, A. P. S., Souza, A. P. C., Gomes, C. M., Silva-Oliveira, G. C., Martins, L. C., Fischer, B., Machado, L. F. A., Vallinoto, A. C. R., Ishak, R., Lemos, J. A. R., & Kupek E. (2019). Human T-lymphotropic virus 1 and 2 among people who used illicit drugs in the state of Pará, northern Brazil. Scientific Reports. 14, 9(1), 14750. 10.1038/s41598-019-51383-7.
Osame, M. (1990) Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. in: Blattner WA. Human Retrovirology: HTLV, New York: Raven, 90; 191-197.
Pereira, A. S., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica. UFSM.
Pineda, M. V., Bouzas, M. B., Remesar, M., Fridman, A., Remondegui, C., Mammana, L., et al. (2019) Relevance of HTLV-1 proviral load in asymptomatic and symptomatic patients living in endemic and non-endemic areas of Argentina. PLoS ONE 14(11): e0225596. https://doi.org/10.1371/journal.pone.0225596.
Proietti, F. A., Carneiro-Proietti, A. B., Catalan-Soares, B. C., & Murphy, E. L. (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 5; 24(39):6058-68.
Schierhout, G., Mcgregor, S., Gessain, A., Einsiedel, L., Martinello, M., & Kaldor, J. (2020). Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies. Lancet. 20(1),133-143. https://doi.org/10.1016/S1473-3099(19)30402-5.
Silva, I. C., Pinheiro, B. T., Nobre, A. F. S., Coelho, J. L. P., Pereira, C. C. C., Ferreira, L. S. C., Almeida, C. P. S., Viana, M. N. S. A., Almeida, D. S., Falcão, J. R., Santos, Y. C. V., Araújo, M. W. L., Borges, M. S., Nascimento, L. D., Valentim, L. S., Casseb, J. S. R., Costa, C. A., & Sousa, M. S. (2018). Moderada endemicidade da infecção pelo vírus linfotrópico-T humano na região metropolitana de Belém, Pará, Brasil / Moderate endemicity of the human T-lymphotropic virus infection in the metropolitan region of Belém, Pará, Brazil. Revista Brasileira de Epidemiologia. 21: e180018. http://dx.doi.org/10.1590/1980-549720180018.
Tanajura, D., Castro, N., Oliveira, P., Neto, A., Muniz, A., Carvalho, N. B., et al. (2015) Neurological manifestations in human T-Cell lymphotropic virus Type 1 (HTLV-1)-infected individuals without HTLV-1-associated myelopathy/ tropical spastic paraparesis: a longitudinal cohort study. Clinical Infectious Diseases. 61:49-56.
Vallinoto, A. C., Pontes, G. S., Muto, N. A., Lopes, I. G., Machado, L. F., Azevedo, V. N., et al. (2006). Identification of human T-cell lymphotropic virus infection in a semi isolated Afro-Brazilian quilombo located in the Marajó Island (Pará, Brazil). Memórias do Instituto Oswaldo Cruz. 101 (1):103-105.
Vallinoto, A. C., Muto, N. A., Pontes, G. S., Machado, L. F., Azevedo, V. N., Santos, S. E., et al. (2004). Serological and molecular evidence of HTLV-I infection among Japanese immigrants living in the Amazon region of Brazil. Japanese journal of infectious diseases. 57(4)156-159.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Izabela Mendonça de Assis; Mariângela Moreno Domingues ; Danilo de Souza Almeida; Louise de Souza Canto Covre; Debora Glenda Lima de La-Roque; Ingrid Christiane Silva; Akim Felipe Santos Nobre; Mariza da Silva Borges; Cássia Cristine Costa Pereira; Barbara Brasil Santana; Antonio Carlos Rosario Vallinoto; Maísa Silva de Sousa
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
